Treatment

QUVIVIQ 50 mg film-coated tablets clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic use (Phase IV)
A multi-center, double-blind, randomized, placebo-controlled, 2-way cross-over post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia
This study is looking at a medicine called daridorexant to see if it helps people who have trouble sleeping (insomnia) and also need to wake up often at night to pee (nocturia). It compares the medicine to a dummy pill to see which works best.
For: Insomnia Disorder · Nocturia
Spain · Germany
Ongoing, recruitingTherapeutic exploratory (Phase II)
Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography, dosefinding study assessing the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to < 18 years with insomnia disorder
This study is looking at a new sleep medicine, daridorexant (also known as QUVIVIQ), for young people aged 10-17 who have trouble sleeping (insomnia). It aims to find the right dose and see how well and safely it works to improve sleep.
For: Insomnia Disorder
Germany · Bulgaria · Spain